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Abstract
The cost of urethral catheterisation injury (UCI) is significant, but the true incidence of patient care error is difficult to 
establish in the absence of specific hospital codes recording difficult urethral catheterisation (DUC) and UCI. For many 
years urologists are familiar passing a non-traumatic hydrophilic guidewire blindly into the bladder to aid urethral catheter 
insertion in difficult circumstances. However, so far, no purpose-built regulated medical device was available on the market 
and clinicians had to improvise. Urethrotech filled that gap and developed the Urethral Catheterisation Device  (UCD®), 
which integrates a standard hydrophilic Nitinol guidewire into a 3-way 16F Silicone urethral catheter design to enable safe 
second-line urethral catheterisation when first-line catheterisation with a standard urethral catheter is unsuccessful. The 
safety and efficacy of  UCD® catheterisation were evaluated in consecutive cohorts of men undergoing cardiac surgery and 
compared to the incidence of DUC and UCI with standard Foley catheterisation. A simple new Male Catheterisation Algo-
rithm is proposed that can deliver a safe male urethral catheterisation treatment protocol for all clinical settings of healthcare 
services, which is easy to implement and integrate into standard catheterisation training programs to manage DUC and avoid 
UCI, empowering a frontline workforce to deliver better patient care.
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Abbreviations
CAUTI  Catheter-associated urinary tract infection
DUC  Difficult urethral catheterisation
IFU  Instruction for use
UCI  Urethral catheterisation injury
UCD®  Urethral catheterisation device
UCT  Urethral catheterisation trolley
Introduction
Urethral catheterisation is one of the commonest proce-
dures performed both in the community and hospital setting. 
Approximately 25% of the patients admitted to hospital will 
have a catheter at some point during their stay [1] and 7% 
of nursing home residents are managed by long-term cath-
eterisation. Foley catheters form about 70% of the market 
and in the United States about 30 million Foley catheters 
were sold in 2017.
In the United States, nursing staff perform the major-
ity of catheterisations for both male and female patients 
with well-established procedure guidelines with particular 
focus on reducing catheter-associated urinary tract infec-
tions (CAUTI’s). Although difficult urethral catheterisa-
tion (DUC) occurs only in a small percentage of urethral 
catheterisations overall, it is an important problem due to 
the number of catheterisations that take place on a daily 
basis throughout the Healthcare Service. Often, multiple 
catheterisation attempts are made, ranging from 1.6 to 3.2, 
before the patient is referred to Urology services causing sig-
nificant urethral catheterisation injury (UCI) in 32% of men 
[2]. Hence, when DUC does occur, the catheterisation emer-
gency can easily escalate out of control, leading to acute UCI 
with bleeding requiring hospital admission for more invasive 
specialist procedures. On the other hand, DUC can delay 
patient care with the risk of cancellation of other remaining 
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planned surgical procedures when pre-operative catheterisa-
tion is mandatory.
Published data on UCI are limited probably due to the 
absence of specific hospital codes for de-facto procedure 
complications and the true incidence of DUC and UCI is 
difficult to establish. Over 1 year within a tertiary teach-
ing hospital, 6% of all urological referrals were related 
to complications arising from male urethral catheterisa-
tion [3]. A calculated incidence of 0.7 iatrogenic urethral 
catheter injuries per 1,000 adult male hospital admissions 
was reported in another single academic tertiary hospital 
[4] and other investigators report UCI to be as common as 
symptomatic urinary tract infection [5].
The cost to treat UCI is about $10,000 per case based 
on a reported UCI incidence of 6.7 per 1000 catheters 
inserted [6]. This yields a total healthcare burden in the 
US of $2 billion dollars per year. These costs are exclusive 
of managing long-term complications of urethral strictures 
or any potential medico-legal costs [7].
Every hospital department and clinical area where 
urethral catheterisation takes place has to deal with the 
unpredictable problem of DUC. Clinical areas where such 
events occur more frequently are ER/OR departments, care 
of the elderly and Palliative care/Nursing homes.
Technological advances in the urethral catheter design 
to solve the problem of DUC were in demand for decades 
[8], thus Urethrotech has developed a purpose-built Ure-
thral Catheterisation Device  (UCD®) for second-line ure-
thral catheterisation based on the well-established clinical 
manoeuvre of passing a tube over a guidewire (Seldinger 
Technique) [9]. Indeed, for years urologists have been 
using this Seldinger principle with varying improvised 
guidewire-catheterisation techniques [10–14], which may 
pose a sharps injury risk apart from violating the integrity 
of the urethral catheter design.
We herewith describe the experience with the new 
Urethrotech  UCD®, which was evaluated and compared 
to a standard catheter performance in a matched cohort of 
men undergoing cardiac surgery. We propose a simple new 
algorithm for male catheterisation in view to prevent UCI.
Materials and methods
The Urethrotech  UCD® integrates a standard hydrophilic 
Nitinol guidewire into a 16F 3-way Silicone Foley catheter 
(Fig. 1). The single-use sterile medical device has a 5-year 
shelf-life and can readily be stocked on any Urethral Cath-
eterisation Trolley (UCT). Once the guidewire is lubricated 
with sterile water or saline, the device is ready to use. The 
intended use of the  UCD® is second-line urethral catheteri-
sation when resistance is encountered during first-line stand-
ard urethral catheterisation (Fig. 2).
Because the  UCD® guidewire and catheter form one unit, 
it’s very easy to pass the guidewire into the bladder where it 
curls up and automatically drags the catheter behind without 
getting stuck in an enlarged prostate, which is the most com-
mon problem of DUC in the elderly.
Once the catheter shaft is inserted fully to the hub and 
urine drains freely [15], the Foley balloon is inflated after 
which the guidewire is removed. The attached  UCD® plug 
closes the guidewire channel, or one could start bladder irri-
gation (or take a direct bladder urine specimen) through the 
same channel.
The main safety feature of the  UCD® is the mate-
rial characteristic and length of the integrated  UCD® 
Fig. 1  Urethrotech Urethral 
Catheterisation Device  (UCD®)
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hydrophilic Nitinol guidewire. Should the guidewire fail 
to pass into the bladder and turn around repeatedly to 
exit at the urethral meatus, the Instruction For Use (IFU) 
instructs the healthcare professional to abandon the pro-
cedure. The  UCD® guidewire will do no harm on its own. 
The second-line catheterisation procedure should also 
be abandoned if resistance is encountered again during 
catheter advancement. Such resistance is likely caused 
by an iatrogenic urological problem, such as bladder neck 
contracture after radical prostatectomy or a dense urethral 
stricture, and the patient requires a diagnostic cystoscopy 
by a urologist for the management of the underlying cause 
of the problem.
In this prospective observational cohort study, the 
safety and efficacy of  UCD® catheterisation were evalu-
ated and compared to a standard Foley catheterisation 
cohort in men undergoing cardiac surgery in a single car-
diothoracic centre. Institutional review board-approval 
for the evaluation was granted and informed consent 
was obtained from all individual participants included 
in the study. The potential complication risk from UCI 
in this cardiac surgery cohort was considerable, in view 
of the fact that all men have to be fully anticoagulated 
at the end of their cardiac procedure (bypass or valve 
replacement), creating a surgical management nightmare 
if urethral bleeding from traumatic catheterisation would 
occur. In group A, 74 consecutive male patients (mean 
age 66.8 years) underwent standard catheterisation using 
a 16F Silicone Foley catheter. In group B, 100 consecu-
tive male patients (mean age 67.2 years) underwent ure-
thral catheterisation using the  UCD®.
In both cohorts, the catheterisation was performed after 
the patient was anaesthetised by theatre nurses trained in 
standard Foley and  UCD® catheterisation. Data on ease-
of-use, adverse events and catheter-related symptoms 
after the procedure were collected prospectively for both 
cohorts.
To substantiate the incidence of difficult/traumatic ure-
thral catheterisation, a retrospective audit of 150 consecu-
tive men undergoing cardiothoracic surgery in the same 
unit was also performed.
Results
127 of 150 patients reviewed retrospectively had complete 
documentation in their clinical notes but none had been con-
sented or counselled about potential urethral catheterisation 
complications. 4 of these patients (2.7%) required suprapu-
bic catheterisation for traumatic or unsuccessful urethral 
catheterisation.
In prospective group A, of the 74 men undergoing standard 
Foley catheterisation, 7 (9%) experienced some form of acute 
or late adverse event related to the catheterisation procedure: 
5 (7%) suffered demonstrable acute adverse events of which 
3 (4%) had significant urethral bleeding, and 2 (3%) patients 
required suprapubic catheterisation because it wasn’t possible 
after repeated attempts to insert the catheter into the bladder 
(Fig. 3). These 2 patients were later found to have an enlarged 
prostate as the cause of failed catheterisation. Another 2 
patients reported ongoing complaints suspected to be related 
to the catheterisation procedure; 1 suffered from urethral pain 
for one month after the procedure and the second complained 
of chronic pain in the perineum (to investigate this further 
was not scope of this study and hence those 2 patients were 
excluded from the graph in Fig. 3).
In group B, all 100 patients undergoing  UCD® catheterisa-
tions were catheterised uneventfully first-pass. They did not 
experience any adverse events during the catheterisation pro-
cedure itself or in the post-operative period. Healthcare pro-
fessionals performing  UCD® catheterisation had no problems 
Fig. 2  New Male Catheterisa-
tion Algorithm to manage dif-
ficult urethral catheterisation
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using the new device and liked the ease-of-use and minimal 
variation from standard catheterisation.
Discussion
Urethral catheterisation injury (UCI) converts a relatively 
simple procedure into an emergency with potential long-
term patient morbidity and significant financial burden to 
both patient and healthcare service, in extremis leading to 
potentially fatal complications of urosepsis and Fournier’s 
gangrene.
Acute UCI complications such as bleeding and false pas-
sage traditionally require catheterisation under cystoscopic 
vision or suprapubic catheter insertion. This usually results 
in unnecessary hospital admission and prolonged hospital 
stay.
The cost of managing UCI was €335,377 ($371,790) dur-
ing a 6-month study period at two hospitals in the UK. 81% 
sustained complications Clavien-Dindo grade 2 or greater 
and the additional length of hospital stay was 9.4 ± 10 (2-53) 
days [6]. These costs did not include management of long-
term complications such as urethral stricture disease. In 
addition, UCI is the commonest catheter-related malprac-
tice claim [7].
Several studies have shown a significant reduction of UCI 
after appropriate training with a fivefold incidence reduction 
from 3.2/1000 to 0.7/1000 [3]. Nevertheless, despite appro-
priate training, the very fact that an enlarged prostate can 
cause distortion of an otherwise straight urethral path into 
the bladder makes it equally impossible to pass a standard 
catheter, irrespective of the eminence of the operator. The 
vast majority of DUC-related urological consultations are 
not due to an underlying luminal constriction, i.e. urethral 
stricture, but when urethral trauma has already occurred in 
the presence of non-constricted but problematic anatomy 
such as in benign hyperplasia of the prostate (BPH); or in 
younger men, the presence of a tight external sphincter due 
to anxiety [16].
DUC or UCI is reported to occur between 0.3 and 3% of 
urethral catheterisations [17] but as high as 32% [2]. The 
main reason for this wide variation is a lack of hospital epi-
sode codes for DUC, which makes accurate assessment of 
UCI prevalence near impossible.
The commonest specialist approach to solve DUC is the 
insertion of the urethral catheter over a guidewire [16]. This 
railroading technique was described by Seldinger in 1953 
[9]. It is therefore not surprising that this technique was rec-
ommended for DUC as well [18]. Urologists like to place 
guidewires under direct vision using a cystoscope. However, 
this is not always a feasible solution since DUC is encoun-
tered in every clinical environment including community 
care, where urological equipment and expertise is not read-
ily available and the patient would need to be referred to a 
hospital.
Since the  Terumo® guidewire came to market in the 
mid-1980s, it is known to urologists that this non-traumatic 
hydrophilic Nitinol guidewire can be placed safely into the 
bladder without vision. The technique of blind guidewire 
insertion has been described initially by Freid and Smith 
[19]. Various improvised ‘Do-It-Yourself’ guidewire cath-
eterisation techniques have since been described [10–14]. 
Some thread the guidewire through one of the eye of the 
catheter, some cut off the tip, and others make a hole at 
the catheter tip with a needle or knife to thread the guide-
wire through; however, in doing so, risk sustaining a sharps/
Fig. 3  Urethral catheterisation 
adverse events. Group A: stand-
ard Foley catheterisation; group 
B:  UCD® catheterisation
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needle-stick injury or damaging the balloon inflation 
channel.
Urethrotech® designed a long overdue innovative urethral 
catheter design to provide frontline staff with a readily avail-
able, sterile and properly regulated consumable to manage 
DUC, which can easily be stocked on any UCT to provide 
safe second-line catheterisation without the need for special-
ist equipment, suitable for all healthcare professionals who 
otherwise place urethral catheters. The pragmatic advan-
tages of the Urethrotech  UCD® are many: having guidewire 
and catheter integrated as a single unit means that DUC can 
now be managed single handedly at the patient’s bedside. 
All it takes to activate the guidewire is a syringe of water! 
Hence, if used in the community, the  UCD® could avoid 
unnecessary referrals to hospital to manage DUC. On top, 
because the  UCD® guidewire runs in the wall of the catheter, 
the urine drainage channel is kept empty and can drain urine 
freely confirming correct placement of the catheter in the 
bladder (apart from the fact that community nurses prefer 
to attach the urine bag before catheter placement to avoid 
urine spillage into the patient’s bed). Once the guidewire is 
the removed after safe  UCD® catheter placement, the guide-
wire channel could be used for irrigation or urine specimen 
collection.
The safety and efficacy of the new Urethrotech  UCD® 
were deliberately evaluated in high-risk patients undergoing 
elective cardiac surgery with a reported UCI incidence of 
4% [20]. Any form of urethral trauma puts these patients at 
high risk of bleeding and its management may compromise 
their surgical outcome. Cardiothoracic surgery often takes 
place in specialist hospitals without immediate access to 
urological support, as in our study. We recorded DUC with 
demonstrable adverse events in 5(7%) of the patients cath-
eterised with a standard catheter (group A). Three (4%) had 
bleeding and two (3%) required risky suprapubic catheteri-
sation. However, patients subsequently undergoing  UCD® 
catheterisation (group B) were all successfully catheterised 
by theatre nursing staff with no adverse events and high user 
satisfaction.
The Urethrotech  UCD® is also useful after specialist urol-
ogy procedures [21] and was successfully implemented in 
our nurse-led TWOC clinic [22, 23]. The National Institute 
for Health and Clinical Excellence (NICE) in the UK has 
accredited the Urethrotech  UCD® as a cost-effective second-
line catheterisation solution to manage DUC [24].
We herewith propose a simple new Male Catheterisa-
tion Algorithm (Fig. 2) that can deliver safe male urethral 
catheterisation for all healthcare services, which is easy to 
implement and integrate into standard catheterisation train-
ing programs to manage DUC and avoid UCI.
Conclusion
The Urethrotech  UCD® provides a ready-to-use sterile medi-
cal device for safe second-line urethral catheterisation to 
manage DUC without the problems associated with various 
improvised techniques. The new Male Catheterisation Algo-
rithm rationalises specialist time and resources (flexible cys-
toscopy) when clinically necessary which is cost-effective in 
its own right. This prospective safety and efficacy evaluation 
study demonstrated that the Urethrotech  UCD® is success-
ful and easy to use even in high-risk patients. Moreover, 
second-line  UCD® catheterisation is easy to implement in 
many different clinical settings with the potential of reducing 
unnecessary Accident and Emergency department attend-
ance and hospital admissions. The  UCD® empowers a com-
prehensive nurse-led male catheterisation service. Avoid-
ing UCI in the first place is not only better patient care but 
inevitably cost-effective.
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